Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06096844
Title field or adapter rule
{'original_value': 'A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-11-01T01:03:03.519331+00:00
Published At
2026-10-29T00:00:00+00:00
Record Updated At
2026-10-29
Source Retrieved At
2026-11-01T01:03:02.902675+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Lung Non-Small Cell Carcinoma", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-29", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06096844"
protocolSection.identificationModule.officialTitle
"A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Advanced Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Arm B (pembrolizumab, chemotherapy)'], 'description': 'Given IV', 'name': 'Carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm A (pembrolizumab)', 'Arm B (pembrolizumab, chemotherapy)'], 'description': 'Undergo CT scan', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm A (pembrolizumab)', 'Arm B (pembrolizumab, chemotherapy)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm B (pembrolizumab, chemotherapy)'], 'description': 'Given IV', 'name': 'Nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm B (pembrolizumab, chemotherapy)'], 'description': 'Given IV', 'name': 'Paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm A (pembrolizumab)', 'Arm B (pembrolizumab, chemotherapy)'], 'description': 'Given IV', 'name': 'Pembrolizumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm B (pembrolizumab, chemotherapy)'], 'description': 'Given IV', 'name': 'Pemetrexed', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm A (pembrolizumab)', 'Arm B (pembrolizumab, chemotherapy)'], 'description': 'Undergo PET', 'name': 'Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm A (pembrolizumab)', 'Arm B (pembrolizumab, chemotherapy)'], 'description': 'Ancillary studies', 'name': 'Questionnaire Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Carboplatin (protocolSection.armsInterventionsModule.interventions[].name)
  • Nab-paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)
  • Paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)
  • Pemetrexed (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.